Link between gut microbiota and health outcomes in inulin -treated obese patients: lessons from the Food4Gut multicenter randomized placebo-controlled trial
This escalating trend underscores obesity as a complex, chronic disease characterized by abnormal or excessive fat accumulation, which significantly increases health risks and places a substantial burden on individuals, healthcare systems, and society as a whole The obesity drug sector has exploded with innovation and investment
GLP-1 medications like Semaglutide and Tirzepatide aren't just another fad
A provider should reassess progress, side effects, hormone markers, metabolic health, and whether the peptide should be continued, adjusted, paused, or stopped
Curr Opin Immunol
The NHS Inform Scotland guidance ties the maintenance schedule to the cause of the deficiency, which is why the plan is revisited rather than left on autopilot